by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
Psilocybin has been fast-tracked by the FDA to become a prescription medication in psychedelic-assisted therapy for depression, but now we’re seeing investors line up to support a new indication for the synthetic compound that’s been made famous—in its organic form—by...
by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
A new study is presenting the first published data from preliminary human trials investigating the effect of psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). The incredibly positive results have been described as just a “taste of things to...
by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
MycoMeditations is a psychedelic-retreat company in Treasure Beach, Jamaica, that facilitates 10-day trips where attendees take psychedelic, or “magic,” mushrooms. Recent research has suggested that magic mushrooms, which contain the psychedelic compound...
by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
There is a magical moment in the pharmaceutical industry when a government approves a new treatment. For companies researching psilocybin, the psychoactive component in psychedelic mushrooms, that moment is now. Late last year, the United States Food and Drug...
by EmpathiCSubstanceS | Nov 7, 2020 | Psychedelic Medicine
At 1 pm on Thursday, August 13, Zide Door—an entheogenic church in Oakland, California, that recognizes cannabis and psilocybin mushrooms as religious sacraments—was raided by Oakland Police Department (OPD) during parishioner visiting hours. Zide Door wasn’t just any...
